Christopher N. Vlangos

5.7k total citations · 2 hit papers
24 papers, 2.8k citations indexed

About

Christopher N. Vlangos is a scholar working on Molecular Biology, Genetics and Nephrology. According to data from OpenAlex, Christopher N. Vlangos has authored 24 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Genetics and 8 papers in Nephrology. Recurrent topics in Christopher N. Vlangos's work include Genomic variations and chromosomal abnormalities (8 papers), Renal Diseases and Glomerulopathies (8 papers) and Renal and related cancers (6 papers). Christopher N. Vlangos is often cited by papers focused on Genomic variations and chromosomal abnormalities (8 papers), Renal Diseases and Glomerulopathies (8 papers) and Renal and related cancers (6 papers). Christopher N. Vlangos collaborates with scholars based in United States, Germany and United Kingdom. Christopher N. Vlangos's co-authors include Gail E. Herman, David T. Miller, Kent D. McKelvey, Wendy K. Chung, C. Sue Richards, Christa Lese Martin, Teri E. Klein, Sherri J. Bale, Michael S. Watson and Sarah H. Elsea and has published in prestigious journals such as Nature Genetics, PLoS ONE and PEDIATRICS.

In The Last Decade

Christopher N. Vlangos

24 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics

2016 1.0k citations Sarah S. Kalia, Sherri J. Bale et al. Genetics in Medicine profile →
ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG)

2021 302 citations David T. Miller, Kristy Lee et al. Genetics in Medicine profile →

Peers

Countries citing papers authored by Christopher N. Vlangos

Since Specialization

Citations

This map shows the geographic impact of Christopher N. Vlangos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher N. Vlangos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher N. Vlangos more than expected).

Fields of papers citing papers by Christopher N. Vlangos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher N. Vlangos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher N. Vlangos. The network helps show where Christopher N. Vlangos may publish in the future.

Co-authorship network of co-authors of Christopher N. Vlangos

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher N. Vlangos. A scholar is included among the top collaborators of Christopher N. Vlangos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher N. Vlangos. Christopher N. Vlangos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG) 2021 ·Genetics in Medicine ·David T. Miller, Kristy Lee, Allan Gordon, Laura M. Amendola, (unknown), Sherri J. Bale, Wendy K. Chung, Michael H. Gollob, Steven M. Harrison, Gail E. Herman, Ray E. Hershberger, Teri E. Klein, Kent D. McKelvey, C. Sue Richards, Christopher N. Vlangos, Douglas R. Stewart, Michael S. Watson, Christa Lese Martin	142
2	ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG) breakdown → 2021 ·Genetics in Medicine ·David T. Miller, Kristy Lee, Wendy K. Chung, Allan Gordon, Gail E. Herman, Teri E. Klein, Douglas R. Stewart, Laura M. Amendola, (unknown), Sherri J. Bale, Michael H. Gollob, Steven M. Harrison, Ray E. Hershberger, Kent D. McKelvey, C. Sue Richards, Christopher N. Vlangos, Michael S. Watson, Christa Lese Martin	302
3	Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics breakdown → 2016 ·Genetics in Medicine ·Sarah S. Kalia, (unknown), Sherri J. Bale, Wendy K. Chung, Christine M. Eng, James P. Evans, Gail E. Herman, Sophia B. Hufnagel, Teri E. Klein, Bruce R. Korf, Kent D. McKelvey, Kelly E. Ormond, C. Sue Richards, Christopher N. Vlangos, Michael S. Watson, Christa Lese Martin, David T. Miller	1023
4	Next-Generation Sequencing Identifies the Danforth's Short Tail Mouse Mutation as a Retrotransposon Insertion Affecting Ptf1a Expression 2013 ·PLoS Genetics ·Christopher N. Vlangos, (unknown), Dan R. Robinson, Arul M. Chinnaiyan, Robert H. Lyons, James D. Cavalcoli, Catherine E. Keegan	15
5	Comprehensive genetic analysis of OEIS complex reveals no evidence for a recurrent microdeletion or duplication 2010 ·American Journal of Medical Genetics Part A ·Christopher N. Vlangos, (unknown), Todd Ackley, Hans van Bokhoven, Joris A. Veltman, Ram Iyer, John M. Park, Kim M. Keppler‐Noreuil, Catherine E. Keegan	21
6	Nineteen novel NPHS1 mutations in a worldwide cohort of patients with congenital nephrotic syndrome (CNS) 2010 ·Nephrology Dialysis Transplantation ·Dominik S. Schoeb, Gil Chernin, Saskia F. Heeringa, Verena Matejas, (unknown), Virginia Vega-Warner, Detlef Böckenhauer, Christopher N. Vlangos, Khemchand N Moorani, Thomas J. Neuhaus, Jameela A. Kari, James W. MacDonald, Pawaree Saisawat, Shazia Ashraf, Buğsu Övünç, Martin Zenker, Friedhelm Hildebrandt, (unknown)	57
7	A Novel TRPC6 Mutation That Causes Childhood FSGS 2009 ·PLoS ONE ·Saskia F. Heeringa, Clemens Möller, Jianyang Du, Lixia Yue, Bernward Hinkes, Gil Chernin, Christopher N. Vlangos, Peter F. Hoyer, Jochen Reiser, Friedhelm Hildebrandt	125
8	Caudal regression in adrenocortical dysplasia (acd) mice is caused by telomere dysfunction with subsequent p53-dependent apoptosis 2009 ·Developmental Biology ·Christopher N. Vlangos, Bridget O’Connor, (unknown), (unknown), (unknown), Catherine E. Keegan	20
9	Diagnosing Smith–Magenis Syndrome and Duplication 17p11.2 Syndrome by RAI1 Gene Copy Number Variation Using Quantitative Real-Time PCR 2008 ·Genetic Testing ·Hoa T. Truong, (unknown), (unknown), Santhosh Girirajan, Stephen R. Williams, Christopher N. Vlangos, Ann C. M. Smith, David J. Bunyan, Paul Roffey, Christopher Blanchard, Sarah H. Elsea	9
10	Low prevalence of NPHS2 mutations in African American children with steroid-resistant nephrotic syndrome 2008 ·Pediatric Nephrology ·Gil Chernin, Saskia F. Heeringa, Rasheed Gbadegesin, Jinhong Liu, Bernward Hinkes, Christopher N. Vlangos, Virginia Vega-Warner, Friedhelm Hildebrandt	36
11	Tom1l2 hypomorphic mice exhibit increased incidence of infections and tumors and abnormal immunologic response 2008 ·Mammalian Genome ·Santhosh Girirajan, Paula M. Hauck, Stephen R. Williams, Christopher N. Vlangos, Barbara Szomju, (unknown), Philip D. Mosier, Kimber L. White, Kathleen L. McCoy, Sarah H. Elsea	18
12	Specific Podocin Mutations Correlate with Age of Onset in Steroid-Resistant Nephrotic Syndrome 2008 ·Journal of the American Society of Nephrology ·Bernward Hinkes, Christopher N. Vlangos, Saskia F. Heeringa, Bettina E. Mucha, Rasheed Gbadegesin, Jinhong Liu, K Hasselbacher, Fatih Özaltın, Friedhelm Hildebrandt	84
13	Thirteen novel NPHS1 mutations in a large cohort of children with congenital nephrotic syndrome 2008 ·Nephrology Dialysis Transplantation ·Saskia F. Heeringa, Christopher N. Vlangos, Gil Chernin, Bernward Hinkes, Rasheed Gbadegesin, (unknown), Bethan E. Hoskins, Fatih Özaltın, Friedhelm Hildebrandt, (unknown)	56
14	Mutational analysis of NPHS2 and WT1 in frequently relapsing and steroid-dependent nephrotic syndrome 2007 ·Pediatric Nephrology ·Rasheed Gbadegesin, Bernward Hinkes, Christopher N. Vlangos, Bettina E. Mucha, Jinhong Liu, (unknown), Friedhelm Hildebrandt	33
15	Smith–Magenis syndrome and moyamoya disease in a patient with del(17)(p11.2p13.1) 2007 ·American Journal of Medical Genetics Part A ·Santhosh Girirajan, Roberto Mendoza‐Londono, Christopher N. Vlangos, Lucie Dupuis, Norma J. Nowak, David J. Bunyan, Eli Hatchwell, Sarah H. Elsea	12
16	Genotype–phenotype correlation in Smith-Magenis syndrome: Evidence that multiple genes in 17p11.2 contribute to the clinical spectrum 2006 ·Genetics in Medicine ·Santhosh Girirajan, Christopher N. Vlangos, Barbara Szomju, Emily Edelman, (unknown), Lucie Dupuis, Marjan M. Nezarati, David J. Bunyan, Sarah H. Elsea	108
17	Diagnostic FISH probes for del(17)(p11.2p11.2) associated with Smith–Magenis syndrome should contain the RAI1 gene 2004 ·American Journal of Medical Genetics Part A ·Christopher N. Vlangos, Meredith Wilson, Jan Blancato, Ann C. M. Smith, Sarah H. Elsea	30
18	Refinement of the Smith–Magenis syndrome critical region to ∼950kb and assessment of 17p11.2 deletions. Are all deletions created equally? 2003 ·Molecular Genetics and Metabolism ·Christopher N. Vlangos	71
19	Genomic organisation of the ∼1.5 Mb Smith-Magenis syndrome critical interval: Transcription map, genomic contig, and candidate gene analysis 2001 ·European Journal of Human Genetics ·(unknown), Christopher N. Vlangos, Parimal Das, Pragna I. Patel, Sarah H. Elsea	25
20	Assignment<footref rid="foot01"><sup>1</sup></footref> of developmentally regulated GTP-binding protein (DRG2) to human chromosome band 17p11.2 with somatic cell hybrids and localization to the Smith-Magenis syndrome critical interval 2000 ·Cytogenetic and Genome Research ·Christopher N. Vlangos, Parimal Das, Pragna I. Patel, Sarah H. Elsea	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact